NEW YORK (Reuters Health) - Two new formulations of drugs traditionally used to treat attention deficit/hyperactivity disorder (ADHD), methylphenidate and d-amphetamine, last longer and have less potential for abuse, according to presentations at the American Psychiatric Association annual meeting in San Diego.
More...